AAAAAA

   
Results: 1-7 |
Results: 7
PTEN mutation, EGFR amplification, and outcome in patients with anaplasticastrocytoma and glioblastoma multiforme
Authors: Smith, JS Tachibana, I Passe, SM Huntley, BK Borell, TJ Iturria, N O'Fallon, JR Schaefer, PL Scheithauer, BW James, CD Buckner, JC Jenkins, RB
Citation: Js. Smith et al., PTEN mutation, EGFR amplification, and outcome in patients with anaplasticastrocytoma and glioblastoma multiforme, J NAT CANC, 93(16), 2001, pp. 1246-1256
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
Authors: Tefferi, A Li, CY Reeder, CB Geyer, SM Allmer, C Levitt, R Michalak, JC Addo, F Krook, JE Witzig, TE Schaefer, PL Mailliard, JA
Citation: A. Tefferi et al., A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia, LEUKEMIA, 15(8), 2001, pp. 1171-1175
A simple stratification factor prognostic for survival in advanced cancer:The Good/Bad/Uncertain index
Authors: Sloan, JA Loprinzi, CL Laurine, JA Novotny, PJ Vargas-Chanes, D Krook, JE O'Connell, MJ Kugler, JW Tirona, MT Kardinal, CG Wiesenfeld, M Tschetter, LK Hatfield, AK Schaefer, PL
Citation: Ja. Sloan et al., A simple stratification factor prognostic for survival in advanced cancer:The Good/Bad/Uncertain index, J CL ONCOL, 19(15), 2001, pp. 3539-3546
Descending influences on escape behavior and motor pattern in the cockroach
Authors: Schaefer, PL Ritzmann, RE
Citation: Pl. Schaefer et Re. Ritzmann, Descending influences on escape behavior and motor pattern in the cockroach, J NEUROBIOL, 49(1), 2001, pp. 9-28
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196
Authors: Sparano, JA O'Neill, A Schaefer, PL Falkson, CI Wood, WC
Citation: Ja. Sparano et al., Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196, J CL ONCOL, 18(12), 2000, pp. 2369-2377
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer
Authors: Weitz, JJ Marschke, RF Sloan, JA Grill, JP Jett, JR Knost, JA Hatfield, AK Zenk, DW Bate, WW Schaefer, PL
Citation: Jj. Weitz et al., A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer, LUNG CANC, 28(2), 2000, pp. 157-162
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression
Authors: Perry, A Jenkins, RB O'Fallon, JR Schaefer, PL Kimmel, DW Mahoney, MR Scheithauer, BW Smith, SM Hill, EM Sebo, TJ Levitt, R Krook, J Tschetter, LK Morton, RF Buckner, JC
Citation: A. Perry et al., Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression, CANCER, 86(4), 1999, pp. 672-683
Risultati: 1-7 |